• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病中的代谢组学生物标志物——一项系统综述

Metabolomic biomarkers in diabetic kidney diseases--A systematic review.

作者信息

Zhang Yumin, Zhang Siwen, Wang Guixia

机构信息

Department of Endocrinology and Metabolism, the First Hospital of Jilin University, Changchun, 130021, China.

Department of Endocrinology and Metabolism, the First Hospital of Jilin University, Changchun, 130021, China.

出版信息

J Diabetes Complications. 2015 Nov-Dec;29(8):1345-51. doi: 10.1016/j.jdiacomp.2015.06.016. Epub 2015 Jul 9.

DOI:10.1016/j.jdiacomp.2015.06.016
PMID:26253264
Abstract

Diabetic kidney disease (DKD) is generally characterized by increasing albuminuria in diabetic patients; however, few biomarkers are available to facilitate early diagnosis of this disease. The application of metabolomics has shown promises addressing this need. In this review, we conducted a search about metabolomic biomarkers in DKD patients through MEDLINE, EMBASE, and Cochrane Database up to the end of March, 2015. 12 eligible studies were selected and evaluated subsequently through the use of QUADOMICS, a quality assessment tool. 7 of the 12 included studies were classified as 'high quality'. We also recorded specific study characteristics including participants' characteristics, metabolomic techniques, sample types, and significantly altered metabolites between DKD and control groups. Products of lipid metabolisms including esterified and non-esterified fatty acids, carnitines, phospholipids and metabolites involved in branch-chained amino acids and aromatic amino acids metabolisms were frequently affected biomarkers of DKD. Other differential metabolites were also found, while some of their associations with DKD were unclear. Further more studies are required to test these findings in larger, diverse ethnic populations with elaborate study designs, and finally we could translate them into the benefits of DKD patients.

摘要

糖尿病肾病(DKD)通常表现为糖尿病患者蛋白尿增加;然而,几乎没有生物标志物可用于促进该疾病的早期诊断。代谢组学的应用已显示出满足这一需求的前景。在本综述中,我们通过检索MEDLINE、EMBASE和Cochrane数据库,对截至2015年3月底的DKD患者代谢组学生物标志物进行了研究。随后,通过使用质量评估工具QUADOMICS,选择并评估了12项符合条件的研究。12项纳入研究中有7项被归类为“高质量”。我们还记录了具体的研究特征,包括参与者特征、代谢组学技术、样本类型以及DKD组和对照组之间显著改变的代谢物。脂质代谢产物,包括酯化和非酯化脂肪酸、肉碱、磷脂以及参与支链氨基酸和芳香族氨基酸代谢的代谢物,是DKD常见的受影响生物标志物。还发现了其他差异代谢物,但其与DKD的一些关联尚不清楚。需要进一步开展更多研究,在更大规模、种族多样的人群中采用精心设计的研究方案来验证这些发现,最终将其转化为DKD患者的益处。

相似文献

1
Metabolomic biomarkers in diabetic kidney diseases--A systematic review.糖尿病肾病中的代谢组学生物标志物——一项系统综述
J Diabetes Complications. 2015 Nov-Dec;29(8):1345-51. doi: 10.1016/j.jdiacomp.2015.06.016. Epub 2015 Jul 9.
2
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.糖尿病肾病的多学科管理:一项系统评价与荟萃分析
JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011.
3
Pentoxifylline for diabetic kidney disease.己酮可可碱用于治疗糖尿病肾病。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD006800. doi: 10.1002/14651858.CD006800.pub2.
4
Vitamin B and its derivatives for diabetic kidney disease.用于治疗糖尿病肾病的维生素B及其衍生物
Cochrane Database Syst Rev. 2015 Jan 12;1(1):CD009403. doi: 10.1002/14651858.CD009403.pub2.
5
Interventions to increase attendance for diabetic retinopathy screening.提高糖尿病视网膜病变筛查参与率的干预措施。
Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.
6
Protein restriction for diabetic kidney disease.限制蛋白质摄入治疗糖尿病肾病。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
7
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
8
Glucose targets for preventing diabetic kidney disease and its progression.预防糖尿病肾病及其进展的血糖目标。
Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD010137. doi: 10.1002/14651858.CD010137.pub2.
9
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
10
Associations of Dietary Protein Intake and Amino Acid Patterns with the Risk of Diabetic Kidney Disease in Adults with Type 2 Diabetes: A Cross-Sectional Study.2型糖尿病成年患者膳食蛋白质摄入量和氨基酸模式与糖尿病肾病风险的关联:一项横断面研究
Nutrients. 2025 Jun 29;17(13):2168. doi: 10.3390/nu17132168.

引用本文的文献

1
Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine.糖尿病肾病中的新兴生物标志物与创新治疗策略:精准医学之路
Diagnostics (Basel). 2025 Apr 11;15(8):973. doi: 10.3390/diagnostics15080973.
2
A comprehensive review of biomarker research in diabetic nephropathy from a global bibliometric and visualization perspective.从全球文献计量学和可视化角度全面综述糖尿病肾病的生物标志物研究。
Medicine (Baltimore). 2024 Nov 29;103(48):e40729. doi: 10.1097/MD.0000000000040729.
3
Lipid metabolism disorder in diabetic kidney disease.
糖尿病肾病中的脂代谢紊乱。
Front Endocrinol (Lausanne). 2024 Apr 29;15:1336402. doi: 10.3389/fendo.2024.1336402. eCollection 2024.
4
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.管状功能障碍损害糖尿病肾病中假尿嘧啶核苷的肾脏排泄。
Am J Physiol Renal Physiol. 2024 Jan 1;326(1):F30-F38. doi: 10.1152/ajprenal.00252.2022. Epub 2023 Nov 2.
5
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies.糖尿病血管病变:分子机制与治疗策略。
Signal Transduct Target Ther. 2023 Apr 10;8(1):152. doi: 10.1038/s41392-023-01400-z.
6
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study.一种广义协变量调整的最优配对算法及其在慢性肾功能不全队列研究(CRIC)中糖尿病肾病分期分类中的应用。
BMC Bioinformatics. 2023 Feb 20;24(1):57. doi: 10.1186/s12859-023-05171-w.
7
The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients.GenoDiabMar注册库:2型糖尿病患者的协作研究平台。
J Clin Med. 2022 Mar 5;11(5):1431. doi: 10.3390/jcm11051431.
8
Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review.代谢健康的超重/肥胖与代谢不健康的超重/肥胖之间的代谢组学特征:一项系统综述
Diabetes Metab Syndr Obes. 2021 Mar 4;14:991-1010. doi: 10.2147/DMSO.S294894. eCollection 2021.
9
A GC-MS-Based Metabolomics Investigation of the Protective Effect of Liu-Wei-Di-Huang-Wan in Type 2 Diabetes Mellitus Mice.基于气相色谱-质谱联用的六味地黄丸对2型糖尿病小鼠保护作用的代谢组学研究
Int J Anal Chem. 2020 Aug 13;2020:1306439. doi: 10.1155/2020/1306439. eCollection 2020.
10
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.糖尿病患者肾功能下降的代谢组学标志物:来自慢性肾功能不全队列(CRIC)研究的证据。
Am J Kidney Dis. 2020 Oct;76(4):511-520. doi: 10.1053/j.ajkd.2020.01.019. Epub 2020 May 5.